COVID-19 Statement – Operational Impact & Our Dedication to the Life Sciences Industry
Posted on April 14, 2020 by Joe Haugh, Zenith Technologies, A Cognizant Company CEO
Tuesday 14th April – At this unprecedented time, Zenith Technologies, A Cognizant Company stands strong in support of the Life Sciences industry as it faces the challenge of operating and supporting public health efforts during the COVID-19 outbreak.
At Zenith we take great pride in working with the best in Life Sciences and are committed to support our customers operations across the globe, so that vital therapies continue to reach patients. We salute all key workers who continue their work for the greater good, and many of our Zenith colleagues who are joined with them at this time. I am proud to say that Zenith are already starting to work on projects with our clients for possible treatments of COVID-19.
Since the outbreak in January and its progression across the world, we have been adjusting how we operate our business, to ensure the safety and well-being of our associates, whilst maintaining the continuity of our critical services to our customers.
To ensure we can continue to support our customers at this time we have adapted our operations model to onsite support of customer manufacturing facilities in critical roles and remote working from home where possible. We have done this in collaboration with our customers, whilst also following our own internal pandemic response and business continuity procedures.
Today Zenith Technologies continues to operate with a level of professionalism and passion that our customers expect and we are ready to deliver support where needed. To mitigate any difficulties, we continue to innovate our ways of working. New ways of working are under continuous review and will ensure we can adapt to the evolving situation.
Now more than ever we must work together to overcome the challenging environment we find ourselves in. Here at Zenith our mission is to make a meaningful difference in Life Sciences, supporting our customers activities in the continued supply of vital treatments to market whilst increasing access to new treatments globally. During this time, we dedicate our services to our customers in their pursuit of improving patient health in whatever way we can.
Thanks again to you all at this time.
Joe Haugh, CEO